Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration

Clinical trial NCT00362180 · COMPLETED

Trial details

NCT number: NCT00362180
Sponsor: Kastle Therapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lipid Metabolism, Inborn Errors Hyperlipidemias Metabolic Diseases Hypolipoproteinemia Hypolipoproteinemias Hypobetalipoproteinemias Metabolism, Inborn Errors Genetic Diseases, Inborn Infant, Newborn, Diseases Congenital Abnormalities Metabolic Disorder Hypercholesterolemia

Start date: 2006-07-01
Primary completion: 2010-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.